Brief: Richter And Mithra Receive Positive CHMP Opinion For Estelle

Gedeon Richter

26/03/2021 12:36

March 26 (Reuters) - Mithra Pharmaceuticals  MITRA.BR :
    * RICHTER AND MITHRA RECEIVE POSITIVE CHMP OPINION FOR
ESTELLE
    * MARKETING AUTHORIZATION VALID FOR ALL EUROPEAN UNION
MEMBER
STATES IS EXPECTED TO BE GRANTED BY THE END OF THE SECOND
QUARTER 2021
    * PRODUCT WILL BE MARKETED IN EUROPE BY RICHTER UNDER THE
BRAND
NAME DROVELIS

Source text: https://bit.ly/3rqYLe3
Further company coverage:  GDRB.BU ;  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))